These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6537913)

  • 41. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy.
    Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS
    Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated carcinoembryonic antigen levels in the milk of a nursing mother with inoperable breast cancer.
    Bartal AH; Kahana L; Yarom J
    Cancer; 1980 Nov; 46(9):2091-2. PubMed ID: 6253050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
    Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM; Staab HJ; Anderer FA
    Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer.
    Wang DY; Bulbrook RA; Hayward JL; Hendrick JC; Franchimont P
    Eur J Cancer (1965); 1975 Sep; 11(9):615-8. PubMed ID: 1220977
    [No Abstract]   [Full Text] [Related]  

  • 48. [CEA and breast neoplasms: application of a personal method for determination of CEA in the clinical study of 242 patients (author's transl)].
    Dell'anna B; Percudani M; Salvadori C
    Bull Cancer; 1979; 66(3):259-67. PubMed ID: 486732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence.
    Clark GW; Ireland AP; Hagen JA; Collard JM; Peters JH; DeMeester TR
    Am J Surg; 1995 Dec; 170(6):597-600; discussion 600-1. PubMed ID: 7492008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients.
    Mujagić Z; Mujagic H; Prnjavorac B
    Med Arh; 2004; 58(1):23-6. PubMed ID: 15017899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor.
    Mansour EG; Hastert M; Park CH; Koehler KA; Petrelli M
    Cancer; 1983 Apr; 51(7):1243-8. PubMed ID: 6825048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological markers for breast carcinoma.
    Waalkes TP; Enterline JP; Shaper JH; Abeloff MD; Ettinger DS
    Cancer; 1984 Feb; 53(3 Suppl):644-51. PubMed ID: 6692267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of postoperative blood levels of carcinoembryonic antigen (CEA) in breast cancer.
    Myers RE; Sutherland DJ; Meakin JW; Malkin DG; Kellen JA; Malkin A
    Recent Results Cancer Res; 1979; 67():26-32. PubMed ID: 451321
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of intracystic carcinoma of the breast: the importance of measuring carcinoembryonic antigen in aspirated cystic fluid.
    Matsuo S; Eto T; Soejima H; Ohara O; Hidaka O; Miyazaki J; Tsunoda T; Kanematsu T
    Breast Cancer Res Treat; 1993 Oct; 28(1):41-4. PubMed ID: 8123868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of Serum Carcinoembryonic Antigen's Profile for Breast Cancer in Western Algeria: 100 cases.
    Tahari Z; Medjdoub A; Sahraoui T; Belhabri L; El Kebir FZ
    Gulf J Oncolog; 2017 Jan; 1(23):33-36. PubMed ID: 28272000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
    Williams MR; Turkes A; Pearson D; Twining P; Griffiths K; Blamey RW
    Eur J Surg Oncol; 1988 Oct; 14(5):417-22. PubMed ID: 3181446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Our experience with the diagnostic and prognostic unreliability of pre- and postoperative CEA in human breast cancer].
    Ovaleo-Pandolfo E; Capelli P; Franciosi V
    Acta Biomed Ateneo Parmense; 1985; 56(2):91-8. PubMed ID: 2930984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
    Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
    Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.
    Lumachi F; Brandes AA; Ermani M; Bruno G; Boccagni P
    Anticancer Res; 2000; 20(6C):4751-5. PubMed ID: 11205212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.